• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于骨组织工程的三维聚合物支架上的改性羟基磷灰石-壳聚糖杂化复合界面涂层

Modified-Hydroxyapatite-Chitosan Hybrid Composite Interfacial Coating on 3D Polymeric Scaffolds for Bone Tissue Engineering.

作者信息

Poddar Deepak, Singh Ankita, Rao Pranshu, Mohanty Sujata, Jain Purnima

机构信息

Department of Chemistry, Netaji Subhas University of Technology, Dwarka Sector 3, New Delhi, 110078, India.

Department of Chemical Engineering, Indian Institute of Technology Delhi, New Delhi, 110016, India.

出版信息

Macromol Biosci. 2023 Dec;23(12):e2300243. doi: 10.1002/mabi.202300243. Epub 2023 Aug 24.

DOI:10.1002/mabi.202300243
PMID:37586699
Abstract

Three dimensional (3D) scaffolds have huge limitations due to their low porosity, mechanical strength, and lack of direct cell-bioactive drug contact. Whereas bisphosphonate drug has the ability to stimulate osteogenesis in osteoblasts and bone marrow mesenchymal stem cells (hMSC) which attracted its therapeutic use. However it is hard administration low bioavailability, and lack of site-specificity, limiting its usage. The proposed scaffold architecture allows cells to access the bioactive surface at their apex by interacting at the scaffold's interfacial layer. The interface of 3D polycaprolactone (PCL) scaffolds has been coated with alendronate-modified hydroxyapatite (MALD) enclosed in a chitosan matrix, to mimic the native environment and stupulate the through interaction of cells to bioactive layer. Where the mechanical strength will be provided by the skeleton of PCL. In the MALD composite's hydroxyapatite (HAP) component will govern alendronate (ALD) release behavior, and HAP presence will drive the increase in local calcium ion concentration increases hMSC proliferation and differentiation. In results, MALD show release of 86.28 ± 0.22. XPS and SEM investigation of the scaffold structure, shows inspiring particle deposition with chitosan over the interface. All scaffolds enhanced cell adhesion, proliferation, and osteocyte differentiation for over a week without in vitro cell toxicity with 3.03 ± 0.2 kPa mechanical strength.

摘要

三维(3D)支架由于其低孔隙率、机械强度以及缺乏细胞与生物活性药物的直接接触而存在巨大局限性。而双膦酸盐药物具有刺激成骨细胞和骨髓间充质干细胞(hMSC)成骨的能力,这吸引了其在治疗方面的应用。然而,它给药困难、生物利用度低且缺乏位点特异性,限制了其使用。所提出的支架结构允许细胞通过在支架界面层相互作用,在其顶端接触生物活性表面。3D聚己内酯(PCL)支架的界面已用包裹在壳聚糖基质中的阿仑膦酸盐修饰的羟基磷灰石(MALD)进行了涂层,以模拟天然环境并刺激细胞与生物活性层的相互作用。其中机械强度将由PCL骨架提供。在MALD复合材料中,羟基磷灰石(HAP)成分将控制阿仑膦酸盐(ALD)的释放行为,并且HAP的存在将促使局部钙离子浓度升高,从而增加hMSC的增殖和分化。结果显示,MALD的释放率为86.28±0.22。对支架结构进行的XPS和SEM研究表明,壳聚糖在界面上有令人鼓舞的颗粒沉积。所有支架在一周多的时间内都增强了细胞黏附、增殖和骨细胞分化,且具有3.03±0.2 kPa的机械强度,无体外细胞毒性。

相似文献

1
Modified-Hydroxyapatite-Chitosan Hybrid Composite Interfacial Coating on 3D Polymeric Scaffolds for Bone Tissue Engineering.用于骨组织工程的三维聚合物支架上的改性羟基磷灰石-壳聚糖杂化复合界面涂层
Macromol Biosci. 2023 Dec;23(12):e2300243. doi: 10.1002/mabi.202300243. Epub 2023 Aug 24.
2
Influence of varying concentrations of chitosan coating on the pore wall of polycaprolactone based porous scaffolds for tissue engineering application.不同浓度壳聚糖涂层对用于组织工程应用的聚己内酯基多孔支架的孔壁的影响。
Carbohydr Polym. 2021 May 1;259:117501. doi: 10.1016/j.carbpol.2020.117501. Epub 2020 Dec 14.
3
[Dopamine modified and cartilage derived morphogenetic protein 1 laden polycaprolactone-hydroxyapatite composite scaffolds fabricated by three-dimensional printing improve chondrogenic differentiation of human bone marrow mesenchymal stem cells].[多巴胺修饰且负载软骨源性形态发生蛋白1的聚己内酯-羟基磷灰石复合支架通过三维打印制备,可改善人骨髓间充质干细胞的软骨分化]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Feb 15;32(2):215-222. doi: 10.7507/1002-1892.201708017.
4
Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (ε-caprolactone)/ hydroxyapatite/collagen scaffolds.三维聚(ε-己内酯)/羟基磷灰石/胶原蛋白支架中骨髓基质细胞的骨诱导与增殖
J Transl Med. 2015 May 8;13:152. doi: 10.1186/s12967-015-0499-8.
5
Improvement of mechanical strength and osteogenic potential of calcium sulfate-based hydroxyapatite 3-dimensional printed scaffolds by ε-polycarbonate coating.通过ε-聚碳酸酯涂层提高硫酸钙基羟基磷灰石三维打印支架的机械强度和成骨潜力。
J Biomater Sci Polym Ed. 2017 Sep;28(13):1256-1270. doi: 10.1080/09205063.2017.1312059. Epub 2017 Jun 21.
6
A polycaprolactone/cuttlefish bone-derived hydroxyapatite composite porous scaffold for bone tissue engineering.一种用于骨组织工程的聚己内酯/乌贼骨衍生羟基磷灰石复合多孔支架
J Biomed Mater Res B Appl Biomater. 2014 Jul;102(5):943-51. doi: 10.1002/jbm.b.33075. Epub 2013 Nov 21.
7
Assembling of electrospun meshes into three-dimensional porous scaffolds for bone repair.将电纺网组装成用于骨修复的三维多孔支架。
Biofabrication. 2017 Feb 14;9(1):015018. doi: 10.1088/1758-5090/aa5c99.
8
Biomineralized hydroxyapatite nanoclay composite scaffolds with polycaprolactone for stem cell-based bone tissue engineering.用于基于干细胞的骨组织工程的生物矿化羟基磷灰石纳米粘土与聚己内酯复合支架
J Biomed Mater Res A. 2015 Jun;103(6):2077-101. doi: 10.1002/jbm.a.35342. Epub 2014 Oct 21.
9
In vitro and in vivo bone formation potential of surface calcium phosphate-coated polycaprolactone and polycaprolactone/bioactive glass composite scaffolds.表面钙磷涂层聚己内酯和聚己内酯/生物玻璃复合支架的体外和体内成骨潜力。
Acta Biomater. 2016 Jan;30:319-333. doi: 10.1016/j.actbio.2015.11.012. Epub 2015 Nov 10.
10
Fabrication and characterization of chitosan/OGP coated porous poly(ε-caprolactone) scaffold for bone tissue engineering.用于骨组织工程的壳聚糖/OGP 涂层多孔聚(ε-己内酯)支架的制备与表征
J Biomater Sci Polym Ed. 2017 Jun;28(9):826-845. doi: 10.1080/09205063.2017.1303867. Epub 2017 Mar 14.

引用本文的文献

1
Application of Hydroxyapatite Composites in Bone Tissue Engineering: A Review.羟基磷灰石复合材料在骨组织工程中的应用:综述
J Funct Biomater. 2025 Apr 2;16(4):127. doi: 10.3390/jfb16040127.
2
An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells.骨组织工程中的主要参与者概述:生物材料、支架和细胞。
Int J Mol Sci. 2024 Mar 29;25(7):3836. doi: 10.3390/ijms25073836.